Nouvelle déclaration d'incident
No de la demande: 2008-4723
Numéro de référence du titulaire d'homologation: 2035568
Nom du titulaire (nom légal complet, aucune abbréviation): Sure-Gro Inc.
Adresse: 150 Savannah Oaks Dr.
Ville: Brantford
État: Ontario
Pays: Canada
Code postal /Zip: N3V 1E7
Incident chez un animal domestique
Pays: CANADA
État: BRITISH COLUMBIA
ARLA No d'homologation 18992 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Wilson Wilsarin, Rat and Mouse Bait Pellets
Inconnu
Inconnu
Propriétaire de l'animal
Cat / Chat
Domestic Shorthair
1
Femme
10
Inconnu
Orale
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Oui
Inconnu
Unknown/Inconnu
Accidental ingestion/Ingestion accident.
(p.ex. description des symptômes tels que la fréquence et la gravité
Caller states that she believes that her landlord may have put some of this product out. Caller thinks there is a chance that her cat may have eaten some of the product because yesterday her cat started `not eating, breathing shallow, difficulty drinking, general discomfort. Recommendation was for her to take the cat to the vet at this time for symptoms. Provided caller with case # and direct lines to (name) , have vet give us a call and we will transfer to the NAPCC for treatment recommendations. Give us a call with any questions or concerns. On September 15, 2008 DVM called the kitty is at home and was doing ok and on vitamin K. Just wanted to make sure what type of LA Anticoagulant this is. Case was reviewed with the vet and that this is a LA Anticoagulant that can cause coagulopathies for months. DVM plans vitamin K for 21 - 28 days, then will repeat coags and continue vitamin K as needed.
Mineure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified